Partner Content Partner Content Neurostimulation Devices Market will achieve 15% CAGR up to ... Neurostimulation Devices Market to reach $19bn by 2025
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
